Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
1 clinical trials · Condition
◉ Watch Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
| Record | Firm | Date |
|---|---|---|
| Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VAY736 in Relapsed or Refractory CLL Patients (NCT02137889) | Novartis Pharmaceuticals | 2012-07-01 |
Track Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) automatically
Every clearance here is in the API, with alerts when new ones post.